Pınar Erel

Ihlas Marmara Evleri - I. Kisim, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy
Published: September 02, 2026

Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study.

Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study.

Journal: Annals of Saudi medicine
Published: June 07, 2026

Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

Journal: Journal of clinical medicine
Published: May 17, 2026

Acquired CD74-ROS1 fusion-mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report.

Acquired CD74-ROS1 fusion-mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report.

Journal: Journal of chemotherapy (Florence, Italy)
Published: April 17, 2026

Oncological Perspective on Bone-Metastatic Colorectal Cancer: a Single-Centre Experience.

Oncological Perspective on Bone-Metastatic Colorectal Cancer: a Single-Centre Experience.

Journal: Journal of gastrointestinal cancer
Published: January 01, 2026

Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Journal: Medicina (Kaunas, Lithuania)
Published: December 03, 2025

Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Journal: Journal of clinical medicine
Published: November 27, 2025

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Journal: Future oncology (London, England)
Published: October 17, 2025

Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study.

Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study.

Journal: Annals of Saudi medicine
Published: August 03, 2025

The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy.

The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy.

Journal: Medicina (Kaunas, Lithuania)
Published: July 22, 2025

Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience.

Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience.

Journal: Nutrition and cancer
Published: May 06, 2025

Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group.

Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group.

Journal: Journal of clinical medicine
Published: February 15, 2025
Showing 1-12 of 25

Last Updated: 09/26/2026